Lifeboat Foundation

In the last year or so we have seen remarkable progress with a number of interventions that target the aging processes to prevent and treat age-related diseases.

Senescent cell clearance has enjoyed lots of media attention and is entering human clinical trials later this year with Unity Biotechnology. We have LysoClear from Ichor Therapeutics moving towards the clinic with a therapy based on the LysoSENS approach advocated for by the SENS Research Foundation, which seeks to treat age-related blindness caused by the accumulation of waste products in the retina cells of patients. Dr. David Sinclair is moving into human trials this year with a therapy aimed at repairing DNA damage, one of the main reasons we are thought to age.

We have had amazing progress in immunotherapy, where the immune system is taught to detect cancer and other diseases far more efficiently. For instance, immunotherapy has been used to allow the immune system spot cancer that uses the same “Do not eat me” signals that healthy cells use to avoid destruction.

Continue reading “We Should Be Optimistic But Not Complacent About Progress” »

According to a new study from Oxford and Yale University researchers, those are the years artificial intelligence is slated to take over each of those tasks. And so it will go for millions of other jobs over the next 50 years, researchers find.

https://www.lifespan.io/campaigns/agemeter-biomarker-scan/#reward_4

The ultimate bundle for those who want the world to see that they support science. This is just one of the fantastic rewards available in the AgeMeter campaign on Lifespan.io, support science today and make da Vinci proud!

Olivia Solon felt more key fob than Robocop after getting implanted with a microchip to make contactless purchases. But the future could hold much more.

Starting with just a digital file, scientists manufactured the common flu virus.

Private sector provides weaponry from robot gunboats to anti-drone systems.

Yesterday, AMD revealed the Project 47 supercomputer was powered by 20 AMD EPYC 7601 processors and 80 Radeon Instinct GPUs. It is a petaFLOP supercomputer in a rack. Other hardware included 10TB of Samsung memory and 20 Mellanox 100G cards (and 1 switch). Project 47 is capable of 1 PetaFLOP of single-precision compute performance or 2 PetaFLOPS of half-precision.

Project 47 is built around the Inventec P47. The P47 is a 2U parallel computing platform designed for graphics virtualization and machine intelligence applications. A single rack of Inventec P47 systems is all that was necessary to achieve 1 PetaFLOP, and it does so while producing 30 GigaFLOPS/Watt, which AMD claims is 25% more efficient than some other competing supercomputing platforms. A petaFLOP system uses 33,333 watts. A thousand of PetaFLOP racks would use 33.3 MW and have an exaFLOP.

Thanks to its 32-core / 64-thread EPYC processors and Radeon Vega GPUs, which feature 4,096 stream processors each, AMD also claims that Project 47 rack has more cores/threads, compute units, I/O lanes and memory channels in use simultaneously than in any other similarly configured system.

Continue reading “AMD reveals PetaFLOP supercomputer in a single rack” »

Dr. Neal Barnard says: “More colorful vegetables and fruits, a 40-minute brisk walk, vitamin E and less dairy products, cheese, and milk can protect you from alzheimer’s and dementia.”

Dr. Neal Barnard has led numerous research studies investigating the effects of diet on diabetes, body weight, and chronic pain, including a groundbreaking study of dietary interventions in type 2 diabetes, funded by the National Institutes of Health. Dr. Barnard has authored over 70 scientific publications as well as 17 books.

Continue reading “More Colorful Vegetables and Fruits Can Protect You From Alzheimer’s and Dementia: Neal Barnard” »